Thermo Fisher Scientific Reports Second Quarter 2019 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Nasdaq leads Wall Street lower on AI spending jitters; oil prices rebound
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Brent hits five-month high on escalating Middle East conflict
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- Abbott plans to spin off its nutrition unit as a standalone public company
- Alphabet shares drop ahead of earnings next week
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Crude Inventory Fell 3.06 Million Barrels Last Week - EIA
- US orders diplomats to depart Saudi Arabia amid Houthi strikes
Thermo Fisher Scientific (TMO) Tops Q2 EPS by 4c; Raises FY19 EPS/Revenue Guidance
July 24, 2019 6:07 AM EDTThermo Fisher Scientific (NYSE: TMO) reported Q2 EPS of $3.04, $0.04 better than the analyst estimate of $3.00. Revenue for the quarter came in at $6.32 billion versus the consensus estimate of $6.3 billion.
Second Quarter 2019 Highlights
Second quarter revenue increased 4% to $6.32 billion.Second quarter GAAP diluted earnings per share (EPS) increased 50% to $2.77.Second quarter adjusted EPS increased 11% to $3.04.Strengthened our mass spectrometry leadership with new instruments, workflows and software, highlighted by two new-generation Thermo Scientific Orbitrap systems the Exploris 480 and Eclipse Tribrid and a new workflow to advance biotherapeutics, called the HR Multi-Attribute Method.... More


